Results 191 to 200 of about 306,294 (257)

Clear cell renal cell carcinoma combined with intravascular large B-cell lymphoma: a case report and review of the literature. [PDF]

Front Oncol
Zheng Z, Shou Y, Zhou J, Liu E, Yang M, Liu X, Wei J.   +6 more
europepmc   +1 more source

Nutrient intake and renal cancer: molecular pathways and mechanistic insights into the protective role of dietary components. [PDF]

Front Nutr
Chen P, Bi X, Tian R, Zhang Q.
europepmc   +1 more source

Plasmonic Heterojunction Nanomaterials for Noninvasive Pan‐Cancer Metabolomic Screening

Interdisciplinary Materials, EarlyView.
This study develops gold nanoparticle‐modified manganese–cobalt oxide heterjunctions (Au/MCOM) as a laser desorption/ionization mass spectrometry (LDI‐MS) matrix for acquiring serum metabolic fingerprints. Combined with machine learning, the platform achieves accurate detection and early screening across six cancer types, demonstrating strong potential
Jia Qi, Hairu Lin, Caiyun Fang, Jia Li, Fangying Shi, Chunhui Deng   +5 more
wiley   +1 more source

Large sarcomatoid chromophobe renal cell carcinoma with tumor thrombus extending into the inferior vena cava: a case report on the challenges and lessons from a fatal outcome. [PDF]

Ann Transl Med
Baez NP, Tekin A, Sleeman D, Alvarez A, Ciancio G.   +4 more
europepmc   +1 more source

HIF2A as a prognostic and clinical therapeutic target in ovarian clear cell carcinoma

International Journal of Cancer, EarlyView.
What's New? Ovarian clear cell carcinoma is highly associated with hypoxia. Hypoxia‐inducible factor 2A (HIF2A) is a key regulator of hypoxic responses, but its role in ovarian clear cell carcinoma remains unclear. This study demonstrated the unfavorable prognostic significance of HIF2A expression in ovarian clear cell carcinoma.
Mengxin Jiang, Ken Yamaguchi, Kohei Hamada, Yuko Hosoe, Yuka Mise, Sachiko Kitamura, Zhihong Liu, Hairong Wei, Zhenhai Gao, Mana Taki, Koji Yamanoi, Ryusuke Murakami, Rin Mizuno, Taito Miyamoto, Junzo Hamanishi, Masaki Mandai   +15 more
wiley   +1 more source

Drug repurposing of ticagrelor suppresses renal cell carcinoma growth by blockading the EGFR/PI3K/AKT axis. [PDF]

Ann Med
Yang Y, Zhang L, Guo Y, Zhou T, Liu T, Fang H, He Y.   +6 more
europepmc   +1 more source

Recurrent Macular Edema Associated With Belzutifan Therapy for Metastatic Renal Cell Carcinoma. [PDF]

J Vitreoretin Dis
Chung ME, Wai KM.
europepmc   +1 more source

Next-generation liquid biopsies: detecting circulating epigenetic changes to identify translocation renal cell carcinoma. [PDF]

J Clin Invest
Ito K, Braun DA.
europepmc   +1 more source

Metachronous primary non-small cell lung cancer and mucinous tubular and spindle cell carcinoma of the left kidney: A case report. [PDF]

Oncol Lett
Zhao JX, Zhu W, Pan JB, Sun PF.
europepmc   +1 more source